A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer

Authors :: Gaponova A.
Nikonova A.
Deneka A.
Kopp M.
Kudinov A.
Skobeleva N.
Khazak V.
Ogawa L.
Cai K.
Duncan K.
Duncan J.
Egleston B.
Proia D.
Boumber Y.
Golemis E.
Source :: SCOPUS10780432-2016-22-20-SID84991577399
Publication Year :: 2016
Abstract: ©2016 AACR.Purpose: Small cell lung cancer (SCLC) is a highly aggressive disease representing 12% to 13% of total lung cancers, with median survival of

Tools